FlyersRights and seven safety experts demand immediate changes to the Boeing 787-9

In the wake of last summer's catastrophic Boeing 787-9 crash that killed 260 people, the nation's largest airline passenger group is demanding immediate inspections and fixes for a dangerous design defect in the popular commercial jet. FlyersRights revealed that, in November 2025, it formally called on the Department of Transportation and Federal Aviation Administration to […]

First Industrial Realty Trust Closes $425 Million and $375 Million Unsecured Term Loans

First Industrial Realty Trust, Inc. (NYSE: FR), a leading fully integrated owner, operator and developer of logistics real estate, today announced the refinancing of its $425 million unsecured term loan with an initial maturity date of January 22, 2030 with a one-year extension option at the Company’s discretion, subject to certain conditions. The term loan

ROSEN, LEADING INVESTOR COUNSEL, Encourages Integer Holdings Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – ITGR

NEW YORK CITY, NY / ACCESS Newswire / January 22, 2026 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Integer Holdings Corporation (NYSE:ITGR) between July 25, 2024 and October 22, 2025, both dates inclusive (the "Class Period"), of the important February 9, 2026 lead plaintiff deadline.

Which Dog Food Qualifies as “Healthy” in 2026? Small Dog vs Senior Dog Needs — Badlands Ranch Superfood Complete Consumer Analysis

LOS ANGELES, CA, Jan. 22, 2026 (GLOBE NEWSWIRE) — This consumer analysis examines search intent and evaluation criteria, not product rankings or endorsements. Disclaimer: This article is for informational purposes only and does not constitute veterinary advice. Always consult a qualified veterinarian before making changes to your pet's diet. This article contains affiliate links. If

UPDATE — Astera Labs Broadens Scorpio X-Series Smart Fabric Switch Roadmap to Address Expanding Scale-Up Market Opportunities

(NASDAQ:ALAB), Scorpio X-Series Begins Initial Production with Merchant Scale-Up Switching Market Estimated to Reach $20 billion by 20301 News Highlights: Developed in collaboration with hyperscalers, Scorpio X-series products are purpose-built to support scale-up networking, and are now shipping in initial production volumes Expanded features will include support for increased radix, platform-specific protocols, in-network computing, Hypercast

Which Dog Food Qualifies as “Healthy” in 2026? Small Dog vs Senior Dog Needs — Badlands Ranch Superfood Complete Consumer Analysis

Which Dog Food Qualifies as “Healthy” in 2026? Small Dog vs Senior Dog Needs — Badlands Ranch Superfood Complete Consumer Analysis Why searches for “Best Healthy Dog Food,” “Healthy Dog Food for Small Dogs,” and “Healthy Dog Food for Senior Dogs” are rising in 2026 — and how consumers evaluate these labels GlobeNewswire January 22,

UPDATE — Astera Labs Broadens Scorpio X-Series Smart Fabric Switch Roadmap to Address Expanding Scale-Up Market Opportunities

UPDATE — Astera Labs Broadens Scorpio X-Series Smart Fabric Switch Roadmap to Address Expanding Scale-Up Market Opportunities GlobeNewswire January 22, 2026 Scorpio X-Series Begins Initial Production with Merchant Scale-Up Switching Market Estimated to Reach $20 billion by 20301 News Highlights: Developed in collaboration with hyperscalers, Scorpio X-series products are purpose-built to support scale-up networking, and

ROSEN, A LEADING LAW FIRM, Encourages Vistagen Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – VTGN

New York, New York–(Newsfile Corp. – January 22, 2026) – WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Vistagen Therapeutics, Inc. (NASDAQ: VTGN) between April 1, 2024 and December 16, 2025, both dates inclusive (the “Class Period”). A class action lawsuit

New Zynex Leadership Responds to Indictment of Former Executives

Zynex, Inc. (ZYXIQ), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management and rehabilitation, today issued the following statement regarding the federal indictments of two former executives. “Zynex, Inc. is aware of the federal indictments of two former executives,” said John Bibb, Chief Legal Officer. The

Did You Lose Money Investing in Vistagen Therapeutics, Inc.? Contact Robbins LLP for Information About Your Rights Against VTGN

SAN DIEGO, CA / ACCESS Newswire / January 22, 2026 / Robbins LLP reminds investors that a class action was filed against Vistagen Therapeutics, Inc. (NASDAQ:VTGN) Vistagen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of therapies for neuropsychiatric and neurological disorders. For more information, submit a form, email attorney Aaron

Scroll to Top